Quigley Pharma, is the drug development subsidiary of The Quigley Corp. It is developing a drug to treat diabetic peripheral neuropathy. In this process it has started selection of the patients for clinical trials. The company will start giving the drug to patients suffering from the disorder from May 15. Later it will make a study about its pharmacokinetic effects. It will go in depth research that how it is absorbed into and metabolized by the body.
New drug for diabetes is on trial
Posted May 4th 2012 at 11:14 am by admin
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or create a trackback from your own site.
There are no comments yet, be the first to say something
